ABSENCE OF P16 MTS1 GENE-MUTATIONS IN HUMAN PROSTATE-CANCER/

Citation
Ww. Chen et al., ABSENCE OF P16 MTS1 GENE-MUTATIONS IN HUMAN PROSTATE-CANCER/, Carcinogenesis, 17(12), 1996, pp. 2603-2607
Citations number
42
Categorie Soggetti
Oncology
Journal title
ISSN journal
01433334
Volume
17
Issue
12
Year of publication
1996
Pages
2603 - 2607
Database
ISI
SICI code
0143-3334(1996)17:12<2603:AOPMGI>2.0.ZU;2-P
Abstract
The tumor suppressor gene p16/MTS1, located on chromosome 9p21, is a c ell cycle regulatory gene which is frequently altered in human cancers , The role of this gene in prostate cancer is unknown, To determine th e frequency of deletions and point mutations of p16/MTS1 in human pros tate cancer, we examined 18 cancer and matched benign and hyperplastic tissue specimens, Deletions of p16/MTS1 were detected by semi-quantit ative multiplex polymerase chain reaction in which a portion of exon 2 of the p16/MTS1 gene and a control marker, the glyceraldehyde 3-phosp hate dehydrogenase gene, were amplified simultaneously, 'Cold' single- stranded conformational polymorphism (SSCP) analysis was performed to examine exons 1 and 2 of the p16/MTS1 gene for point mutations, Our da ta indicate no evidence for intragenic homozygous deletion in the pros tate tumors, One prostate tumor and matched benign tissue showed mobil ity shifts, Direct DNA sequencing of the SSCP positive samples showed a G --> A transition in codon 140 which would result in an amino acid change from alanine to threonine, Our results indicate that deletions and point mutations in the p16/MTS1 gene are rare and do not play a ma jor role in human prostate carcinogenesis.